Skip to content

Josefin Lundgren

Forskningsinfrastrukturernas centrala roll inom life science

Under senaste tid har forskningsinfrastrukturernas roll uppmärksammats och diskuterats flitigt. Betänkandet Stärkt fokus på framtidens forskningsinfrastruktur (SOU 2021:65) har besvarats med remissyttranden och Life Science kontoret har arrangerat årlig life science konferens.

Antibiotic research pushed forward by use of large infrastructures

Robert Schnell is a scientist at Karolinska Institute focusing on development of novel antibiotic candidates. He has used both SciLifeLab and MAX IV laboratory infrastructures in a multifaceted project addressing the problem of infectious diseases in the context of the silent pandemic of antimicrobial resistance (AMR).